Witnessing the stock’s movement on the chart, on April 30, 2021, Frequency Therapeutics Inc. (NASDAQ: FREQ) set off with pace as it heaved 3.94% to $11.61. During the day, the stock rose to $12.19 and sunk to $10.96 before settling in for the price of $11.17 at the close. Taking a more long-term approach, FREQ posted a 52-week range of $7.34-$58.37.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -29.30%. This publicly-traded company’s shares outstanding now amounts to $33.82 million, simultaneously with a float of $26.29 million. The organization now has a market capitalization sitting at $381.85 million. At the time of writing, stock’s 50-day Moving Average stood at $24.40, while the 200-day Moving Average is $27.12.
It is imperative to bring your focus towards the efficiency factor of the conglomerate that has a total of 83 employees. It has generated 425,103 per worker during the last fiscal year. Meanwhile, its income per employee was -304,724. The stock had 64.60 Receivables turnover and 0.15 Total Asset turnover. For the Profitability, stocks gross margin was +95.73, operating margin was -74.49 and Pretax Margin of -71.59.
Frequency Therapeutics Inc. (FREQ) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Frequency Therapeutics Inc.’s current insider ownership accounts for 2.50%, in contrast to 64.50% institutional ownership. According to the most recent insider trade that took place on Mar 01, this organization’s President and CEO sold 9,416 shares at the rate of 50.43, making the entire transaction reach 474,836 in total value, affecting insider ownership by 308,086. Preceding that transaction, on Feb 08, Company’s President and CEO sold 16,554 for 55.00, making the whole transaction’s value amount to 910,470. This particular insider is now the holder of 308,086 in total.
Frequency Therapeutics Inc. (FREQ) Earnings and Revenue Records
As on 12/30/2020, Multinational firm has announced its last quarter scores, in which it reported -$0.3 earnings per share (EPS) for the period falling under the consensus outlook (set at -$0.25) by -$0.05. This company achieved a net margin of -71.68 while generating a return on equity of -14.73. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.28 per share during the current fiscal year.
Frequency Therapeutics Inc.’s EPS decrease for this current 12-month fiscal period is -29.30% and is forecasted to reach -1.27 in the upcoming year.
Frequency Therapeutics Inc. (NASDAQ: FREQ) Trading Performance Indicators
Let’s observe the current performance indicators for Frequency Therapeutics Inc. (FREQ). It’s Quick Ratio in the last reported quarter now stands at 8.50. The Stock has managed to achieve an average true range (ATR) of 0.99. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 10.32.
In the same vein, FREQ’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.82, a figure that is expected to reach -0.28 in the next quarter, and analysts are predicting that it will be -1.27 at the market close of one year from today.
Technical Analysis of Frequency Therapeutics Inc. (FREQ)
Going through the that latest performance of [Frequency Therapeutics Inc., FREQ]. Its last 5-days volume of 0.81 million was inferior to the volume of 1.18 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 81.48% While, its Average True Range was 1.14.
Raw Stochastic average of Frequency Therapeutics Inc. (FREQ) in the period of the previous 100 days is set at 8.38%, which indicates a major fall in contrast to 81.11% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 42.44% that was lower than 266.03% volatility it exhibited in the past 100-days period.